To Evaluate the PK, PD, Safety and Drug Tolerance of JW0302 in Healthy Volunteers
Clinical trial NCT05784155 · COMPLETED
Trial details
- NCT number
- NCT05784155
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-10
- Primary completion
- 2023-06-09
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.